TCL Archive Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program August 22, 1980
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey. February 16, 2001
